Evidence map›Paper›PMID 29456260›Full record

ArticleIEEE transactions on electromagnetic compatibility2017

RF Safety Evaluation of a Breast Tissue Expander Device for MRI: Numerical Simulation and Experiment.

Bu S Park, Amir Razjouyan, Leonardo M Angelone, Brent McCright, Sunder S Rajan

Abstract read
In one paragraph

Article in IEEE transactions on electromagnetic compatibility, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bu S ParkU.S. FDA, CBER, OTAT Division of Cellular and Gene Therapies, Silver Spring, MD 20993-0002 USA.
Amir RazjouyanU.S. FDA, CDRH, OSEL, Division of Biomedical Physics, Silver Spring, MD 20993-0002 USA.
Leonardo M AngeloneU.S. FDA, CDRH, OSEL, Division of Biomedical Physics, Silver Spring, MD 20993-0002 USA.
Brent McCrightU.S. FDA, CBER, OTAT Division of Cellular and Gene Therapies, Silver Spring, MD 20993-0002 USA.
Sunder S RajanU.S. FDA, CDRH, OSEL, Division of Biomedical Physics, Silver Spring, MD 20993-0002 USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

This study describes the MRI-related radio frequency (RF) safety evaluation of breast tissue expander devices to establish safety criteria. Numerical simulations and experimental measurements were performed at 64 MHz with a gel phantom containing a breast expander. Additionally, computational modeling was performed (64 and 128 MHz) with an adult female model, containing a virtually implanted breast tissue expander device for four imaging landmark positions. The presence of the breast tissue expander device led to significant alterations in specific absorption rate (SAR) and|B

Indexed as

Computational modelingfinite difference time domain (FDTD)landmarksspecific absorption rate (SAR)women’s health

Identifiers

PMID29456260
PMCPMC5814144

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.